SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-May-24 4:01 PM View: | Springworks Therapeutics, I... (SWTX) | 16-May-24 | Grant | 4,095 | -- | -- | 28% 14.71K to 18.8K | |
25-May-23 10:00 PM View: | Springworks Therapeutics, I... (SWTX) | 24-May-23 | Grant | 4,648 | -- | -- | 46% 10.06K to 14.71K | |
15-Jul-22 6:07 AM View: | Springworks Therapeutics, I... (SWTX) | 14-Jul-22 | Grant | 10,058 | -- | -- | 100% 0 to 10.06K | |
18-Nov-20 5:04 PM View: | Abbvie Inc. (ABBV) | 16-Nov-20 | Option Exercise | 115,830 | $35.88 | $4,155,980.00 | 75% 155.34K to 271.17K | |
18-Nov-20 5:04 PM View: | Abbvie Inc. (ABBV) | 16-Nov-20 | Market Option Sale | 115,830 | $100.00 | $11,583,000.00 | (43%) 271.17K to 155.34K | (3%) |
08-Jul-20 9:19 PM View: | Abbvie Inc. (ABBV) | 07-Jul-20 | Market Sale | 53,325 | $100.00 | $5,332,550.00 | (26%) 208.67K to 155.34K | (< 1%) |
03-Mar-20 4:51 PM View: | Abbvie Inc. (ABBV) | 28-Feb-20 | Payment of Exercise | 32,092 | $85.42 | $2,741,300.00 | (13%) 240.76K to 208.67K | (16%) |
24-Feb-20 6:04 PM View: | Abbvie Inc. (ABBV) | 20-Feb-20 | Grant | 72,439 | -- | -- | 43% 168.32K to 240.76K | |
04-Mar-19 4:53 PM View: | Abbvie Inc. (ABBV) | 28-Feb-19 | Payment of Exercise | 24,125 | $79.41 | $1,915,770.00 | (13%) 192.44K to 168.32K | (21%) |
22-Feb-19 5:20 PM View: | Abbvie Inc. (ABBV) | 21-Feb-19 | Grant | 54,450 | -- | -- | 39% 137.99K to 192.44K | |
02-Mar-18 5:29 PM View: | Abbvie Inc. (ABBV) | 01-Mar-18 | Option Exercise | 48,100 | $29.23 | $1,405,790.00 | 28% 170.89K to 218.99K | |
02-Mar-18 5:29 PM View: | Abbvie Inc. (ABBV) | 01-Mar-18 | Market Option Sale | 45,521 | $114.39 | $5,207,030.00 | (21%) 218.99K to 173.47K | 18% |
02-Mar-18 5:29 PM View: | Abbvie Inc. (ABBV) | 01-Mar-18 | Market Sale | 35,474 | $114.39 | $4,057,780.00 | (20%) 173.47K to 137.99K | 18% |
02-Mar-18 5:29 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Payment of Exercise | 25,976 | $118.26 | $3,071,920.00 | (13%) 199.44K to 173.47K | 20% |
02-Mar-18 5:29 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Market Option Sale | 2,579 | $117.85 | $303,928.00 | (1%) 173.47K to 170.89K | 20% |
16-Feb-18 5:53 PM View: | Abbvie Inc. (ABBV) | 15-Feb-18 | Grant | 44,257 | -- | -- | 29% 155.19K to 199.44K | |
15-Jun-17 5:05 PM View: | Abbvie Inc. (ABBV) | 14-Jun-17 | Option Exercise | 45,800 | $24.21 | $1,108,740.00 | 30% 155.19K to 200.99K | |
15-Jun-17 5:05 PM View: | Abbvie Inc. (ABBV) | 14-Jun-17 | Market Option Sale | 45,800 | $70.00 | $3,206,000.00 | (23%) 200.99K to 155.19K | (31%) |
08-May-17 5:13 PM View: | Abbvie Inc. (ABBV) | 04-May-17 | Market Sale | 43,000 | $67.00 | $2,881,000.00 | (22%) 198.19K to 155.19K | (37%) |
02-Mar-17 6:10 PM View: | Abbvie Inc. (ABBV) | 28-Feb-17 | Payment of Exercise | 34,721 | $62.22 | $2,160,340.00 | (15%) 232.91K to 198.19K | (46%) |
21-Feb-17 5:50 PM View: | Abbvie Inc. (ABBV) | 16-Feb-17 | Grant | 43,022 | -- | -- | 23% 189.89K to 232.91K | |
12-May-16 5:39 PM View: | Abbvie Inc. (ABBV) | 10-May-16 | Market Sale | 47,438 | $63.52 | $3,013,260.00 | (20%) 237.32K to 189.89K | (45%) |
02-Mar-16 5:18 PM View: | Abbvie Inc. (ABBV) | 29-Feb-16 | Payment of Exercise | 39,930 | $56.00 | $2,236,080.00 | (14%) 277.25K to 237.32K | (66%) |
03-Mar-15 6:03 PM View: | Abbvie Inc. (ABBV) | 28-Feb-15 | Payment of Exercise | 7,200 | $60.50 | $435,600.00 | (3%) 284.45K to 277.25K | (59%) |
03-Mar-15 6:03 PM View: | Abbvie Inc. (ABBV) | 27-Feb-15 | Payment of Exercise | 12,706 | $60.52 | $768,967.00 | (4%) 297.16K to 284.45K | (59%) |
23-Feb-15 5:07 PM View: | Abbvie Inc. (ABBV) | 19-Feb-15 | Grant | 51,580 | -- | -- | 21% 245.58K to 297.16K | |
04-Mar-14 5:10 PM View: | Abbvie Inc. (ABBV) | 03-Mar-14 | Market Sale | 2,882 | $50.09 | $144,356.00 | (1%) 248.46K to 245.58K | (98%) |
04-Mar-14 5:10 PM View: | Abbvie Inc. (ABBV) | 28-Feb-14 | Payment of Exercise | 15,319 | $50.91 | $779,890.00 | (6%) 263.78K to 248.46K | (95%) |
24-Feb-14 5:06 PM View: | Abbvie Inc. (ABBV) | 20-Feb-14 | Grant | 47,260 | -- | -- | 22% 216.52K to 263.78K | |
03-May-13 5:27 PM View: | Abbvie Inc. (ABBV) | 01-May-13 | Option Exercise | 142,900 | $27.95 | $3,994,050.00 | 76% 187.28K to 330.18K | |
03-May-13 5:27 PM View: | Abbvie Inc. (ABBV) | 01-May-13 | Market Option Sale | 113,656 | $45.68 | $5,191,390.00 | (34%) 330.18K to 216.52K | (121%) |
04-Mar-13 5:09 PM View: | Abbvie Inc. (ABBV) | 28-Feb-13 | Payment of Exercise | 12,960 | $36.73 | $476,021.00 | (6%) 200.24K to 187.28K | (177%) |
19-Feb-13 7:06 PM View: | Abbvie Inc. (ABBV) | 19-Feb-13 | Payment of Exercise | 9,826 | $37.58 | $369,261.00 | (5%) 210.06K to 200.24K | (171%) |
19-Feb-13 7:06 PM View: | Abbvie Inc. (ABBV) | 14-Feb-13 | Grant | 56,700 | -- | -- | 37% 153.36K to 210.06K | |
07-Feb-13 4:44 PM View: | Abbvie Inc. (ABBV) | 05-Feb-13 | Payment of Exercise | 2,325 | $37.28 | $86,676.00 | (1%) 155.69K to 153.36K | |
07-Feb-13 4:44 PM View: | Abbvie Inc. (ABBV) | 05-Feb-13 | Option Exercise | 2,482 | $33.80 | $83,886.60 | 2% 153.21K to 155.69K | |
04-Dec-12 5:11 PM View: | Abbott Laboratories (ABT) | 01-Dec-12 | Grant | 18,453 | -- | -- | 16% 117.69K to 136.14K | |
04-Dec-12 5:11 PM View: | Abbott Laboratories (ABT) | 16-Nov-12 | Gift | 40,442 | -- | -- | 34% 117.69K to 158.13K | |
04-Dec-12 5:11 PM View: | Abbott Laboratories (ABT) | 16-Nov-12 | Gift | 40,442 | -- | -- | (26%) 158.13K to 117.69K | |
17-Oct-12 5:03 PM View: | Abbott Laboratories (ABT) | 15-Oct-12 | Grant | 4,900 | -- | -- | 4% 114.82K to 119.72K | |
17-Oct-12 5:03 PM View: | Abbott Laboratories (ABT) | 15-Oct-12 | Payment of Exercise | 2,032 | $69.28 | $140,777.00 | (2%) 119.72K to 117.69K | (244%) |
27-Sep-12 5:10 PM View: | Abbott Laboratories (ABT) | 25-Sep-12 | Option Exercise | 1,198 | $57.25 | $68,585.50 | 1% 114.82K to 116.02K | |
27-Sep-12 5:10 PM View: | Abbott Laboratories (ABT) | 25-Sep-12 | Market Option Sale | 1,198 | $70.00 | $83,860.00 | (1%) 116.02K to 114.82K | (243%) |
21-Sep-12 5:09 PM View: | Abbott Laboratories (ABT) | 20-Sep-12 | Option Exercise | 1,918 | $56.98 | $109,288.00 | 2% 114.82K to 116.73K | |
21-Sep-12 5:09 PM View: | Abbott Laboratories (ABT) | 20-Sep-12 | Market Option Sale | 1,918 | $69.75 | $133,780.00 | (2%) 116.73K to 114.82K | (244%) |
17-Sep-12 5:06 PM View: | Abbott Laboratories (ABT) | 13-Sep-12 | Option Exercise | 1,331 | $56.00 | $74,536.00 | 1% 114.82K to 116.15K | |
17-Sep-12 5:06 PM View: | Abbott Laboratories (ABT) | 13-Sep-12 | Market Option Sale | 1,331 | $68.75 | $91,506.20 | (1%) 116.15K to 114.82K | (249%) |
01-Aug-12 5:29 PM View: | Abbott Laboratories (ABT) | 30-Jul-12 | Market Sale | 352 | $66.62 | $23,451.30 | (< 1%) 115.17K to 114.82K | (257%) |
30-Jul-12 5:05 PM View: | Abbott Laboratories (ABT) | 27-Jul-12 | Option Exercise | 44,837 | $43.11 | $1,933,090.00 | 39% 115.17K to 160.01K | |
30-Jul-12 5:05 PM View: | Abbott Laboratories (ABT) | 27-Jul-12 | Market Option Sale | 44,837 | $65.03 | $2,915,940.00 | (28%) 160.01K to 115.17K | (266%) |